Tercica, Genentech File Motion To Block Insmed Growth Therapy
Drug makers Tercica Inc. and Genentech Inc. have have filed a motion for a preliminary injunction to block Insmed Inc. from bringing its SomatoKine growth therapy to market ahead of a...To view the full article, register now.
Already a subscriber? Click here to view full article